Literature DB >> 28366665

The Phe932Ile mutation in KCNT1 channels associated with severe epilepsy, delayed myelination and leukoencephalopathy produces a loss-of-function channel phenotype.

Katherine M Evely1, Kerri D Pryce2, Arin Bhattacharjee3.   

Abstract

Sodium-activated potassium (KNa) channels contribute to firing frequency adaptation and slow after hyperpolarization. The KCNT1 gene (also known as SLACK) encodes a KNa subunit that is expressed throughout the central and peripheral nervous systems. Missense mutations of the SLACK C-terminus have been reported in several patients with rare forms of early onset epilepsy and in some cases severely delayed myelination. To date, such mutations identified in patients with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE), epilepsy of infancy with migrating focal seizures (EIMFS) and Ohtahara syndrome (OS) have been reported to be gain-of-function mutations (Villa and Combi, 2016). An exome sequencing study identified a p.Phe932Ile KCNT1 mutation as the disease-causing change in a child with severe early infantile epileptic encephalopathy and abnormal myelination (Vanderver et al., 2014). We characterized an analogous mutation in the rat Slack channel and unexpectedly found this mutation to produce a loss-of-function phenotype. In an effort to restore current, we tested the known Slack channel opener loxapine. Loxapine exhibited no effect, indicating that this mutation either caused the channel to be insensitive to this established opener or proper translation and trafficking to the membrane was disrupted. Protein analysis confirmed that while total mutant protein did not differ from wild type, membrane expression of the mutant channel was substantially reduced. Although gain-of-function mutations to the Slack channel are linked to epileptic phenotypes, this is the first reported loss-of-function mutation linked to severe epilepsy and delayed myelination.
Copyright © 2017 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Kcnt1; Slack channel; early infantile epilepsy; leukoencephalopathy; loss-of-function; mutation

Mesh:

Substances:

Year:  2017        PMID: 28366665      PMCID: PMC5479566          DOI: 10.1016/j.neuroscience.2017.03.035

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  24 in total

1.  Formation of intermediate-conductance calcium-activated potassium channels by interaction of Slack and Slo subunits.

Authors:  W J Joiner; M D Tang; L Y Wang; S I Dworetzky; C G Boissard; L Gan; V K Gribkoff; L K Kaczmarek
Journal:  Nat Neurosci       Date:  1998-10       Impact factor: 24.884

2.  Slack sodium-activated potassium channel membrane expression requires p38 mitogen-activated protein kinase phosphorylation.

Authors:  Sushmitha Gururaj; John Fleites; Arin Bhattacharjee
Journal:  Neuropharmacology       Date:  2015-12-22       Impact factor: 5.250

Review 3.  For K+ channels, Na+ is the new Ca2+.

Authors:  Arin Bhattacharjee; Leonard K Kaczmarek
Journal:  Trends Neurosci       Date:  2005-08       Impact factor: 13.837

4.  Identification of a novel de novo p.Phe932Ile KCNT1 mutation in a patient with leukoencephalopathy and severe epilepsy.

Authors:  Adeline Vanderver; Cas Simons; Johanna L Schmidt; Philip L Pearl; Miriam Bloom; Bennett Lavenstein; David Miller; Sean M Grimmond; Ryan J Taft
Journal:  Pediatr Neurol       Date:  2013-10-10       Impact factor: 3.372

5.  Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy.

Authors:  Sarah E Heron; Katherine R Smith; Melanie Bahlo; Lino Nobili; Esther Kahana; Laura Licchetta; Karen L Oliver; Aziz Mazarib; Zaid Afawi; Amos Korczyn; Giuseppe Plazzi; Steven Petrou; Samuel F Berkovic; Ingrid E Scheffer; Leanne M Dibbens
Journal:  Nat Genet       Date:  2012-10-21       Impact factor: 38.330

Review 6.  Molecular genetics of infantile nervous system channelopathies.

Authors:  Mark Gardiner
Journal:  Early Hum Dev       Date:  2006-10-17       Impact factor: 2.079

7.  Epilepsy-Related Slack Channel Mutants Lead to Channel Over-Activity by Two Different Mechanisms.

Authors:  Qiong-Yao Tang; Fei-Fei Zhang; Jie Xu; Ran Wang; Jian Chen; Diomedes E Logothetis; Zhe Zhang
Journal:  Cell Rep       Date:  2015-12-24       Impact factor: 9.423

8.  The antipsychotic drug loxapine is an opener of the sodium-activated potassium channel slack (Slo2.2).

Authors:  B Biton; S Sethuramanujam; Kelly E Picchione; A Bhattacharjee; N Khessibi; F Chesney; C Lanneau; O Curet; P Avenet
Journal:  J Pharmacol Exp Ther       Date:  2011-12-13       Impact factor: 4.030

9.  Slack channels expressed in sensory neurons control neuropathic pain in mice.

Authors:  Ruirui Lu; Anne E Bausch; Wiebke Kallenborn-Gerhardt; Carsten Stoetzer; Natasja Debruin; Peter Ruth; Gerd Geisslinger; Andreas Leffler; Robert Lukowski; Achim Schmidtko
Journal:  J Neurosci       Date:  2015-01-21       Impact factor: 6.167

10.  KCNT1 gain of function in 2 epilepsy phenotypes is reversed by quinidine.

Authors:  Carol J Milligan; Melody Li; Elena V Gazina; Sarah E Heron; Umesh Nair; Chantel Trager; Christopher A Reid; Anu Venkat; Donald P Younkin; Dennis J Dlugos; Slavé Petrovski; David B Goldstein; Leanne M Dibbens; Ingrid E Scheffer; Samuel F Berkovic; Steven Petrou
Journal:  Ann Neurol       Date:  2014-04-14       Impact factor: 10.422

View more
  9 in total

1.  Phactr1 regulates Slack (KCNT1) channels via protein phosphatase 1 (PP1).

Authors:  Syed Rydwan Ali; Taylor Joseph Malone; Yalan Zhang; Magdalena Prechova; Leonard Konrad Kaczmarek
Journal:  FASEB J       Date:  2019-12-02       Impact factor: 5.191

Review 2.  The Functional Properties, Physiological Roles, Channelopathy and Pharmacological Characteristics of the Slack (KCNT1) Channel.

Authors:  Qi Zhang; Ye Liu; Jie Xu; Yue Teng; Zhe Zhang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  HRPU-2, a Homolog of Mammalian hnRNP U, Regulates Synaptic Transmission by Controlling the Expression of SLO-2 Potassium Channel in Caenorhabditis elegans.

Authors:  Ping Liu; Sijie Jason Wang; Zhao-Wen Wang; Bojun Chen
Journal:  J Neurosci       Date:  2017-12-07       Impact factor: 6.167

Review 4.  Impact of predictive, preventive and precision medicine strategies in epilepsy.

Authors:  Rima Nabbout; Mathieu Kuchenbuch
Journal:  Nat Rev Neurol       Date:  2020-10-19       Impact factor: 42.937

5.  Slo2 potassium channel function depends on RNA editing-regulated expression of a SCYL1 protein.

Authors:  Long-Gang Niu; Ping Liu; Zhao-Wen Wang; Bojun Chen
Journal:  Elife       Date:  2020-04-21       Impact factor: 8.140

6.  The Epilepsy of Infancy With Migrating Focal Seizures: Identification of de novo Mutations of the KCNT2 Gene That Exert Inhibitory Effects on the Corresponding Heteromeric KNa1.1/KNa1.2 Potassium Channel.

Authors:  Xiao Mao; Nadine Bruneau; Quwen Gao; Hélène Becq; Zhengjun Jia; Hui Xi; Li Shu; Hua Wang; Pierre Szepetowski; Laurent Aniksztejn
Journal:  Front Cell Neurosci       Date:  2020-01-24       Impact factor: 5.505

7.  The Na+-activated K+ channel Slack contributes to synaptic development and plasticity.

Authors:  Lucas Matt; Thomas Pham; David Skrabak; Felix Hoffmann; Philipp Eckert; Jiaqi Yin; Miriam Gisevius; Rebekka Ehinger; Anne Bausch; Marius Ueffing; Karsten Boldt; Peter Ruth; Robert Lukowski
Journal:  Cell Mol Life Sci       Date:  2021-10-18       Impact factor: 9.261

8.  KNa1.1 gain-of-function preferentially dampens excitability of murine parvalbumin-positive interneurons.

Authors:  Tracy S Gertler; Suraj Cherian; Jean-Marc DeKeyser; Jennifer A Kearney; Alfred L George
Journal:  Neurobiol Dis       Date:  2022-03-26       Impact factor: 7.046

9.  Impaired motor skill learning and altered seizure susceptibility in mice with loss or gain of function of the Kcnt1 gene encoding Slack (KNa1.1) Na+-activated K+ channels.

Authors:  Imran H Quraishi; Michael R Mercier; Heather McClure; Rachael L Couture; Michael L Schwartz; Robert Lukowski; Peter Ruth; Leonard K Kaczmarek
Journal:  Sci Rep       Date:  2020-02-21       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.